Yoshio Koyanagi

15.9k total citations · 6 hit papers
222 papers, 12.8k citations indexed

About

Yoshio Koyanagi is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Yoshio Koyanagi has authored 222 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Virology, 115 papers in Immunology and 56 papers in Infectious Diseases. Recurrent topics in Yoshio Koyanagi's work include HIV Research and Treatment (129 papers), T-cell and Retrovirus Studies (55 papers) and Animal Disease Management and Epidemiology (52 papers). Yoshio Koyanagi is often cited by papers focused on HIV Research and Treatment (129 papers), T-cell and Retrovirus Studies (55 papers) and Animal Disease Management and Epidemiology (52 papers). Yoshio Koyanagi collaborates with scholars based in Japan, United States and Germany. Yoshio Koyanagi's co-authors include Naoki Yamamoto, Shinji Harada, Irvin S. Y. Chen, Naoko Misawa, Kei Sato, Mamoru Ito, Hirotaka Ebina, Steven A. Miles, Harry V. Vinters and Yuetsu Tanaka and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Yoshio Koyanagi

220 papers receiving 12.5k citations

Hit Papers

NOD/SCID/γcnull mouse: an excellent recipient mous... 1985 2026 1998 2012 2002 1985 1987 1990 2013 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
    2002 1.1k citations Yoshio Koyanagi et al. profile →
  2. Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
    1985 790 citations Shinji Harada, Yoshio Koyanagi et al. profile →
  3. Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular Tropisms
    1987 727 citations Yoshio Koyanagi et al. profile →
  4. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
    1990 503 citations Yoshio Koyanagi et al. profile →
  5. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
    2013 431 citations Hirotaka Ebina, Naoko Misawa et al. Scientific Reports profile →
  6. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
    2020 312 citations Izumi Kimura, Masaya Fukushi et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshio Koyanagi Japan 55 6.4k 6.0k 3.7k 3.1k 2.1k 222 12.8k
Scott Koenig United States 55 6.1k 1.0× 5.9k 1.0× 4.0k 1.1× 2.8k 0.9× 3.4k 1.6× 102 13.6k
Mark B. Feinberg United States 53 7.3k 1.2× 6.4k 1.1× 3.9k 1.1× 2.1k 0.7× 2.9k 1.4× 107 12.2k
Paul R. Clapham United Kingdom 53 10.2k 1.6× 7.8k 1.3× 4.7k 1.3× 2.7k 0.9× 2.7k 1.2× 127 14.4k
George N. Pavlakis United States 71 6.0k 0.9× 6.0k 1.0× 3.1k 0.9× 7.7k 2.5× 2.4k 1.1× 248 16.3k
Lee Ratner United States 64 8.6k 1.4× 7.1k 1.2× 5.4k 1.5× 4.9k 1.6× 2.4k 1.1× 300 17.5k
Barbara K. Felber United States 60 4.8k 0.8× 4.8k 0.8× 2.3k 0.6× 5.7k 1.8× 1.8k 0.9× 197 12.0k
Marjorie Robert-Guroff United States 53 5.1k 0.8× 7.1k 1.2× 2.3k 0.6× 1.8k 0.6× 2.2k 1.0× 195 11.4k
Fatah Kashanchi United States 59 3.2k 0.5× 3.0k 0.5× 2.4k 0.6× 6.1k 2.0× 1.2k 0.6× 257 10.6k
Genoveffa Franchini United States 66 5.1k 0.8× 9.4k 1.6× 1.9k 0.5× 2.6k 0.8× 2.6k 1.2× 263 14.1k
Paul A. Luciw United States 63 8.1k 1.3× 4.0k 0.7× 4.2k 1.2× 4.5k 1.5× 4.4k 2.1× 200 14.3k

Countries citing papers authored by Yoshio Koyanagi

Since Specialization
Citations

This map shows the geographic impact of Yoshio Koyanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Koyanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Koyanagi more than expected).

Fields of papers citing papers by Yoshio Koyanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Koyanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Koyanagi. The network helps show where Yoshio Koyanagi may publish in the future.

Co-authorship network of co-authors of Yoshio Koyanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Koyanagi. A scholar is included among the top collaborators of Yoshio Koyanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Koyanagi. Yoshio Koyanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasunaga, Jun‐ichirou, Kei Sato, Kisato Nosaka, et al.. (2024). Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses. Proceedings of the National Academy of Sciences. 121(13). e2309925121–e2309925121. 13 indexed citations
2.
Iwanami, Shoya, Katrina B. Mar, Naoko Misawa, et al.. (2022). Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection. PLoS Computational Biology. 18(4). e1010053–e1010053. 2 indexed citations
3.
Kim, Kwang Su, Yoshiki Koizumi, Shinji Nakaoka, et al.. (2020). Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model. Journal of Theoretical Biology. 498. 110295–110295. 1 indexed citations
4.
Ito, Jumpei, Izumi Kimura, Alexandre Coudray, et al.. (2020). Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression. Science Advances. 6(43). 41 indexed citations
5.
Nagaoka, Shumpei, Eiryo Kawakami, Jumpei Ito, et al.. (2020). Multiomics Investigation Revealing the Characteristics of HIV-1-Infected Cells In Vivo. Cell Reports. 32(2). 107887–107887. 14 indexed citations
6.
Nakano, Yusuke, Naoko Misawa, Shinji Nakaoka, et al.. (2017). HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation. PLoS Pathogens. 13(5). e1006348–e1006348. 30 indexed citations
7.
Ueda, Shuhei, Hirotaka Ebina, Yuka Kanemura, Naoko Misawa, & Yoshio Koyanagi. (2016). Anti‐HIV‐1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication. Microbiology and Immunology. 60(7). 483–496. 52 indexed citations
8.
Iwami, Shingo, Kei Sato, Satoru Morita, et al.. (2015). Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin. Scientific Reports. 5(1). 12256–12256. 10 indexed citations
9.
Ikeda, Hiroki, Shinji Nakaoka, Kei Sato, et al.. (2015). Effect of eclipse phase on quantifying viral dynamics of acute HIV-1 infection in humanized mouse model. Nonlinear Theory and Its Applications IEICE. 6(1). 47–53. 2 indexed citations
10.
Watanabe, Tadashi, Emiko Urano, Kosuke Miyauchi, et al.. (2011). The Hematopoietic Cell-Specific Rho GTPase Inhibitor ARHGDIB/D4GDI Limits HIV Type 1 Replication. AIDS Research and Human Retroviruses. 28(8). 913–922. 20 indexed citations
11.
Hoshino, Shigeki, Binlian Sun, Mitsuru Konishi, et al.. (2007). Vpr in Plasma of HIV Type 1-Positive Patients Is Correlated with The HIV Type 1 RNA Titers. AIDS Research and Human Retroviruses. 23(3). 391–397. 48 indexed citations
12.
Komano, Jun, Emiko Urano, Tôru Aoki, et al.. (2007). Separate elements are required for ligand‐dependent and ‐independent internalization of metastatic potentiator CXCR4. Cancer Science. 98(3). 373–379. 22 indexed citations
13.
Ohkura, Sadayuki, Masahiro Yamashita, Takafumi Ishida, et al.. (2005). Phylogenetic Heterogeneity of new HTLV Type 1 Isolates from Southern India in Subgroup A. AIDS Research and Human Retroviruses. 21(4). 325–330. 5 indexed citations
14.
Takeuchi, Hiroaki, Youichi Suzuki, Masashi Tatsumi, et al.. (2002). Isolation and Characterization of an Infectious HIV Type 1 Molecular Clone from a Patient with Primary Infection. AIDS Research and Human Retroviruses. 18(15). 1127–1133. 8 indexed citations
15.
Kusagawa, Shigeru, Yutaka Takebe, Rongge Yang, et al.. (2001). Isolation and Characterization of a Full-Length Molecular DNA Clone of Ghanaian HIV Type 1 Intersubtype A/G Recombinant CRF02_AG, Which Is Replication Competent in a Restricted Host Range. AIDS Research and Human Retroviruses. 17(7). 649–655. 11 indexed citations
16.
Ishikawa, Koichi, Wouter Janssens, J. Piedade, et al.. (2001). Genetic Analysis of HIV Type 2 from Ghana and Guinea-Bissau, West Africa. AIDS Research and Human Retroviruses. 17(17). 1661–1663. 10 indexed citations
17.
18.
Kinjo, Takao, et al.. (1999). Coxsackievirus B4 Myocarditis in an Orangutan. Veterinary Pathology. 36(5). 452–456. 14 indexed citations
19.
Kira, Jun‐ichi, Minoru Nakamura, Takashi Sawada, et al.. (1992). Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load. Journal of the Neurological Sciences. 107(1). 98–104. 56 indexed citations
20.
Koyanagi, Yoshio, Susumu Kobayashi, Shinji Harada, et al.. (1983). DETECTION OF ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUSES TYPE I AND III IN JAPANESE HEMOPHILIACS. PubMed. 1(5). 353–358. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Koenig Breakdown of academic impact, for papers by Mark B. Feinberg Breakdown of academic impact, for papers by Paul R. Clapham Breakdown of academic impact, for papers by George N. Pavlakis Breakdown of academic impact, for papers by Lee Ratner Breakdown of academic impact, for papers by Barbara K. Felber Breakdown of academic impact, for papers by Marjorie Robert-Guroff Breakdown of academic impact, for papers by Fatah Kashanchi Breakdown of academic impact, for papers by Genoveffa Franchini Breakdown of academic impact, for papers by Paul A. Luciw
Rankless by CCL
2026